抗环瓜氨酸肽抗体作为抗合成酶综合征中侵蚀性关节炎的标志物。 - Suppr

Suppr

超能文献

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

作者信息

Cavagna Lorenzo, Fusetti Chiara, Montecucco Carlomaurizio, Caporali Roberto

出版信息

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

DOI:10.3899/jrheum.091402

PMID:20810525

Abstract

摘要

相似文献

Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome.

J Rheumatol. 2010 Sep;37(9):1967; author reply 1968. doi: 10.3899/jrheum.091402.

Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.

J Rheumatol. 2004 May;31(5):1012-3; author reply 1013.

Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.

J Rheumatol. 2009 Sep;36(9):2133-4. doi: 10.3899/jrheum.090183.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.

Lupus. 2009 Jul;18(8):713-7. doi: 10.1177/0961203309102817.

Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.

J Rheumatol. 2009 Apr;36(4):663-4. doi: 10.3899/jrheum.090184.

[Jo-1-(antisynthetase-) syndrome--do autoantibodies improve classification of myositis?].

Z Rheumatol. 1993 Sep-Oct;52(5):259-63.

Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.

Arthritis Res Ther. 2005;7(3):R592-603. doi: 10.1186/ar1719. Epub 2005 Mar 17.

Antisynthetase syndrome without myositis secondary to AA amyloidosis: a non-described association.

Nefrologia. 2011;31(1):117-9. doi: 10.3265/Nefrologia.pre2010.Sep.10469.

[Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].

Rev Med Suisse. 2005 Mar 9;1(10):674, 677-8, 680 passim.

引用本文的文献

Defining anti-synthetase syndrome: a systematic literature review.

Clin Exp Rheumatol. 2022 Feb;40(2):309-319. doi: 10.55563/clinexprheumatol/8xj0b9. Epub 2022 Feb 25.

[Diffuse interstitial lung disease revealing anti-synthetase syndrome: about two cases].

Pan Afr Med J. 2019 Jan 22;32:40. doi: 10.11604/pamj.2019.32.40.17903. eCollection 2019.

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome.

Clin Rheumatol. 2019 May;38(5):1477-1483. doi: 10.1007/s10067-019-04471-y. Epub 2019 Feb 27.

Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.

Clin Rev Allergy Immunol. 2017 Feb;52(1):71-80. doi: 10.1007/s12016-016-8528-9.

Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.

Medicine (Baltimore). 2015 Aug;94(32):e1144. doi: 10.1097/MD.0000000000001144.

In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.

Medicine (Baltimore). 2015 May;94(20):e523. doi: 10.1097/MD.0000000000000523.

New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.

ScientificWorldJournal. 2014 Jan 29;2014:179180. doi: 10.1155/2014/179180. eCollection 2014.

The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.

Biomed Res Int. 2013;2013:759760. doi: 10.1155/2013/759760. Epub 2013 Sep 25.

Clinical heterogeneity and outcomes of antisynthetase syndrome.

Curr Rheumatol Rep. 2013 Aug;15(8):349. doi: 10.1007/s11926-013-0349-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验